The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Schnitzler's syndrome: diagnosis, treatment, and follow‐up
Open accessAbstract
Schnitzler's syndrome is characterized by recurrent urticarial rash and monoclonal gammopathy, associated with clinical and biological signs of inflammation and a long‐term risk of AA amyloidosis and overt lymphoproliferation. An extensive literature review was performed, and the following questions were addressed during an expert meeting: In whom should Schnitzler's syndrome be suspected? How should the diagnosis of Schnitzler's syndrome be established? How should a patient with Schnitzler's syndrome be treated? How should a patient with Schnitzler's syndrome be followed up?. A diagnosis of Schnitzler's syndrome is considered definite in any patient with two obligate criteria: a recurrent urticarial rash and a monoclonal IgM gammopathy, and two of the following minor criteria: recurrent fever, objective signs of abnormal bone remodeling, elevated CRP level or leukocytosis, and a neutrophilic infiltrate on skin biopsy. It is considered probable, if only 1 minor criterion is present. In patients with monoclonal IgG gammopathies, diagnosis is definite if three minor criteria are present and possible if two are present. First‐line treatment in patients with significant alteration of quality of life or persistent elevation of markers of inflammation should be anakinra. Follow‐up should include clinical evaluation, CBC and CRP every 3 months and MGUS as usually recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-term follow-up of IgM monoclonal gammopathy of undetermined significance
Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Remstein, E. D., Offord, J. R., Larson, D. R., Plevak, M. F., & Melton, L. J. (2003) · Blood · doi:10.1182/blood-2003-03-0801 · Cited by 325
de Koning, H. D., Bodar, E. J., van der Meer, J. W. M., & Simon, A. (2007) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2007.04.001 · Cited by 245
Self-citationKieffer, C., Cribier, B., & Lipsker, D. (2009) · Medicine · doi:10.1097/md.0b013e3181943f5e · Cited by 238
Self-citationLipsker, D. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-38 · Cited by 177
Self-citationKrause, K., Weller, K., Stefaniak, R., Wittkowski, H., Altrichter, S., Siebenhaar, F., Zuberbier, T., & Maurer, M. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02843.x · Cited by 134
Self-citationClinical and histopathologic review of Schnitzler syndrome: The Mayo Clinic experience (1972-2011)
Sokumbi, O., Drage, L. A., & Peters, M. S. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.04.027 · Cited by 81
Self-citationComplete remission in 3 of 3 anti-IL-6–treated patients with Schnitzler syndrome
Krause, K., Feist, E., Fiene, M., Kallinich, T., & Maurer, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.10.031 · Cited by 80
Self-citationSchnitzler syndrome: Treatment failure to rituximab but response to anakinra
Eiling, E., Möller, M., Kreiselmaier, I., Brasch, J., & Schwarz, T. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.03.036 · Cited by 75
Loock, J., Lamprecht, P., Timmann, C., Mrowietz, U., Csernok, E., & Gross, W. L. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.066 · Cited by 62
Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome
de Koning, H. D., Schalkwijk, J., van der Meer, J. W. M., & Simon, A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.05.023 · Cited by 50
Self-citation
Cited by
Treating inflammation by blocking interleukin-1 in humans
Dinarello, C. A., & van der Meer, J. W. M. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.008 · Cited by 549
BSACI guideline for the management of chronic urticaria and angioedema
Powell, R. J., Leech, S. C., Till, S., Huber, P. A. J., Nasser, S. M., & Clark, A. T. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12494 · Cited by 377
Unmet medical needs in chronic, non-communicable inflammatory skin diseases
Ujiie, H., Rosmarin, D., Schön, M. P., Ständer, S., Boch, K., Metz, M., Maurer, M., Thaci, D., Schmidt, E., Cole, C., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.875492 · Cited by 158
Metadata
- Authors
- Simon, A., Asli, B., Braun‐Falco, M., De Koning, H., Fermand, J. ‐., Grattan, C., Krause, K., Lachmann, H., Lenormand, C., Martinez‐Taboada, V., Maurer, M., Peters, M., Rizzi, R., Rongioletti, F., Ruzicka, T., Schnitzler, L., Schubert, B., Sibilia, J., & Lipsker, D.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2013-03-09
- Volume
- 68
- Issue
- 5
- Pages
- 562-568
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W2038864991
- Cited by
- 282
- References
- 12
- FWCI
- 7.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Schnitzler's syndrome: diagnosis, treatment, and follow‐up. https://app.cochat.ai/papers/10.1111/all.12129
- The paper
- Simon, A., Asli, B., Braun‐Falco, M., De Koning, H., Fermand, J. ‐., Grattan, C., Krause, K., Lachmann, H., Lenormand, C., Martinez‐Taboada, V., Maurer, M., Peters, M., Rizzi, R., Rongioletti, F., Ruzicka, T., Schnitzler, L., Schubert, B., Sibilia, J., & Lipsker, D. (2013). Schnitzler's syndrome: diagnosis, treatment, and follow‐up. Allergy. https://doi.org/10.1111/all.12129
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.